Home Health Moderna, Merck Revive mRNA Hopes With Melanoma Success
Health

Moderna, Merck Revive mRNA Hopes With Melanoma Success

Key Points

A personalized vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Madison Muller explains (Source: Bloomberg)

A personalized vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Madison Muller explains (Source: Bloomberg)
Moderna (ORG) Merck (ORG) mRNA (ORG) Madison Muller (PERSON)
Originally published by Bloomberg Markets Read original →